Upashita Intravenous Injection for Dialysis 25μg Syringe contains upacicalcet sodium hydrate and is manufactured by Sanwa Chemical Research Institute. Upashita is used to treat secondary hyperparathyroidism in patients undergoing hemodialysis. This injectable drug, with YJ code 3999460G1021, is supplied as 25μg in 1mL per tube.
Upashita Intravenous Injection for Dialysis 25μg Syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).